Clinical trial

Study Of Patients With Allergic Rhinitis And Asthma

NCT00296530 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00296530
Title Study Of Patients With Allergic Rhinitis And Asthma
Official title A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg QD Versus Montelukast 10mg QD in Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Who Are…
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions fluticasone propionate/salmeterol, fluticasone propionate, montelukast
Enrollment 600
Start date Sep 1, 2005
Primary completion Jul 1, 2007
Completion Jul 1, 2007
First posted Feb 27, 2006
Last update posted Oct 28, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies